- Home
- NVCT vs HOV Comparison
NVCT vs HOV Comparison
Compare NVCT & HOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVCT | HOV |
|---|---|---|
| Founded | 2020 | 1959 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 608.8M | 726.0M |
| IPO Year | 2021 | 1994 |
Fundamental Metrics
Financial Performance| Metric | NVCT | HOV |
|---|---|---|
| Price | $19.32 | $136.42 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 1 | 2 |
| Target Price | $10.00 | ★ $97.00 |
| AVG Volume (30 Days) | ★ 218.9K | 123.7K |
| Earning Date | 05-06-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.20 |
| Revenue | N/A | ★ $2,978,581,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.96 |
| P/E Ratio | ★ N/A | $61.99 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.55 | $91.52 |
| 52 Week High | $29.28 | $162.06 |
Technical Indicators
Market Signals| Indicator | NVCT | HOV |
|---|---|---|
| Relative Strength Index (RSI) | 50.25 | 54.46 |
| Support Level | $17.98 | $97.80 |
| Resistance Level | $23.12 | $138.19 |
| Average True Range (ATR) | 1.46 | 5.58 |
| MACD | -0.28 | 0.10 |
| Stochastic Oscillator | 25.62 | 73.42 |
Price Performance
Historical ComparisonAbout NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About HOV Hovnanian Enterprises Inc.
Hovnanian Enterprises Inc conducts all of its homebuilding and financial services operations. The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It has two distinct operations: homebuilding and financial services. Its homebuilding operations are divided geographically into three segments: Northeast, which includes Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia, and West Virginia; Southeast, which includes Florida, Georgia, and South Carolina; and West, which includes Arizona, California, and Texas. The firm generates maximum revenue from the West Segment.